HONOLULU -- Although single maintenance and reliever therapy (SMART, or MART) marks a new chapter in asthma treatment, its advocates acknowledged practical limitations during a debate at the CHEST ...

Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen and over 40 percent of academic pulmonary and allergy clinicians ...

Despite effective pharmacological options for treating asthma, most patients fail to achieve good control. 1 Non-adherence is common, with over-reliance on short-acting P2-agonists (SABA) and ...

Use of single maintenance and reliever therapy (SMART) for moderate-to-severe asthma saved money by improving outcomes, according to a meta-analysis. While SMART is recommended by guidelines, ...

Please provide your email address to receive an email when new articles are posted on . Single maintenance and reliever therapy (SMART) had a lower total annual asthma management cost vs. traditional ...

The management of asthma has changed since the introduction of budesonide/formoterol (Symbicort ®) as both maintenance and reliever therapy (SMART). SMART and its effects on bronchial ...

Adding a LAMA to inhaled corticosteroids reduces the risk for asthma exacerbations compared with placebo plus inhaled corticosteroids, according to one review. However, the combination was no better ...

Thought LeadersKrisnah PoinasamyHead of Research and Innovation AdvocacyAsthma UK and the British Lung Foundation In commemoration of World Asthma Day 2021, News-Medical interviews Krisnah Poinasamy ...

A staggering 34 million people in India suffer from asthma - a chronic lung condition where airways become inflamed and produce excess mucus, making breathing difficult. This account for nearly 13 per ...

Use of single maintenance and reliever therapy (SMART) for moderate-to-severe asthma reduced healthcare costs, according to a meta-analysis. The single-inhaler approach cut total annual asthma ...